Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Incardona

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Bioinformatics (Oxford, England)|September 30, 2017
PhyloGeoTool: interactively exploring large phylogenies in an epidemiological contextPieter Libin, Ewout Vanden Eynden, Francesca Incardona, et al.
Intervirology|January 31, 2012
Predicting response to antiretroviral treatment by machine learning: the EuResist projectMaurizio Zazzi, Francesca Incardona, Michal Rosen-Zvi, et al.
Plos One|February 9, 2010
Only slight impact of predicted replicative capacity for therapy response predictionHendrik Weisser, André Altmann, Saleta Sierra, et al.
Viruses|November 27, 2024
Spectrum of Non-Nucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living with HIV-1 Receiving RilpivirinePavithra Nagarajan, Jinru Zhou, Giulia Di Teodoro, et al.
The Journal of Infection|March 9, 2019
Longer-term effectiveness of protease-inhibitor-based second line antiretroviral therapy in four large sub-Saharan African clinicsFred S Sarfo, Barbara Castelnuovo, Iuri Fanti, et al.
Frontiers in Microbiology|May 2, 2022
Trends of Transmitted and Acquired Drug Resistance in Europe From 1981 to 2019: A Comparison Between the Populations of Late Presenters and Non-late PresentersMafalda N S Miranda, Marta Pingarilho, Victor Pimentel, et al.
Bioinformatics (Oxford, England)|July 1, 2008
Selecting anti-HIV therapies based on a variety of genomic and clinical factorsMichal Rosen-Zvi, Andre Altmann, Mattia Prosperi, et al.
Plos One|November 22, 2019
Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European surveyAndrea De Luca, Patrizio Pezzotti, Charles Boucher, et al.
Journal of Medical Virology|December 9, 2022
Analysis of mutational history of multidrug-resistant genotypes with a mutagenetic tree modelMartin Pirkl, Joachim Büch, Carole Devaux, et al.
Plos One|October 23, 2008
Comparison of classifier fusion methods for predicting response to anti HIV-1 therapyAndré Altmann, Michal Rosen-Zvi, Mattia Prosperi, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Bioinformatics (Oxford, England)|September 30, 2017
PhyloGeoTool: interactively exploring large phylogenies in an epidemiological contextPieter Libin, Ewout Vanden Eynden, Francesca Incardona, et al.
Intervirology|January 31, 2012
Predicting response to antiretroviral treatment by machine learning: the EuResist projectMaurizio Zazzi, Francesca Incardona, Michal Rosen-Zvi, et al.
Plos One|February 9, 2010
Only slight impact of predicted replicative capacity for therapy response predictionHendrik Weisser, André Altmann, Saleta Sierra, et al.
Viruses|November 27, 2024
Spectrum of Non-Nucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living with HIV-1 Receiving RilpivirinePavithra Nagarajan, Jinru Zhou, Giulia Di Teodoro, et al.
The Journal of Infection|March 9, 2019
Longer-term effectiveness of protease-inhibitor-based second line antiretroviral therapy in four large sub-Saharan African clinicsFred S Sarfo, Barbara Castelnuovo, Iuri Fanti, et al.
Frontiers in Microbiology|May 2, 2022
Trends of Transmitted and Acquired Drug Resistance in Europe From 1981 to 2019: A Comparison Between the Populations of Late Presenters and Non-late PresentersMafalda N S Miranda, Marta Pingarilho, Victor Pimentel, et al.
Bioinformatics (Oxford, England)|July 1, 2008
Selecting anti-HIV therapies based on a variety of genomic and clinical factorsMichal Rosen-Zvi, Andre Altmann, Mattia Prosperi, et al.
Plos One|November 22, 2019
Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European surveyAndrea De Luca, Patrizio Pezzotti, Charles Boucher, et al.
Journal of Medical Virology|December 9, 2022
Analysis of mutational history of multidrug-resistant genotypes with a mutagenetic tree modelMartin Pirkl, Joachim Büch, Carole Devaux, et al.
Plos One|October 23, 2008
Comparison of classifier fusion methods for predicting response to anti HIV-1 therapyAndré Altmann, Michal Rosen-Zvi, Mattia Prosperi, et al.
Pageof 5